USAQ USA Equities
USA Equities Corp. is a development stage company, which currently no operations and has determined to direct its efforts and limited resources to pursue acquisitions and/or effect a business combination, principally in incoming acquiring real estate. The company was founded on September 1, 1983 and is headquartered in West Palm Beach, FL.
Company profile
Ticker
USAQ
Exchange
Website
CEO
Troy Grogan
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Alibaba Group Holding • Visa • Uber • EBay • PayPal • Nielsen • Accenture • Conduent • Mastercard • MultiPlan ...
Former names
AMERICAN BIOGENETIC SCIENCES INC
SEC CIK
Corporate docs
IRS number
112655906
USAQ stock data
()
Investment data
Securities sold
Number of investors
Calendar
11 Mar 21
13 Apr 21
31 Dec 21
Financial summary
Quarter (USD) |
Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial data from company earnings reports.
Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 94.34K | 94.34K | 94.34K | 94.34K | 94.34K | 94.34K |
Cash burn (monthly) | (positive/no burn) | (positive/no burn) | 27.52K | 24.7K | 13.05K | 13.8K |
Cash used (since last report) | n/a | n/a | 95.13K | 85.37K | 45.09K | 47.69K |
Cash remaining | n/a | n/a | -785.05 | 8.97K | 49.25K | 46.65K |
Runway (months of cash) | n/a | n/a | -0.0 | 0.4 | 3.8 | 3.4 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Feb 20 | Troy James Grogan | Convertible Promissory Note Common Stock | Other | Aquire J | No | No | 73500 | 1 | 73.5K | 3 |
Financial report summary
?Content analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absence, absolute, Advisor, aggregate, allergic, AllergiEnd, allergist, amortization, appeal, asthma, ASU, attended, automatically, began, biotechnology, body, broaden, Certified, charge, charging, classification, compounded, condensed, confirmation, constantly, constrained, contact, CPT, critical, culprit, curve, Description, desensitize, developmental, diagnose, discount, distinct, doctor, domain, duration, England, excellent, excessive, Exhibit, extinguishment, FASB, FIFO, flexibility, Footnote, forfeited, foster, FTE, historical, historically, immune, impairment, infrequent, insolvent, introduce, introduced, inventory, line, margin, masking, method, Minister, mission, modification, Newcastle, nurse, onetime, oral, OTCQB, outbreak, owed, page, PCP, pediatrician, pharmacy, placement, possession, preliminary, premium, prescription, project, projected, prolonged, reaction, ready, recoverability, regular, reserve, safety, sample, secrecy, senior, separate, shipping, simplification, skin, slowly, small, solution, specialist, spectrum, strain, stream, studied, sublingual, Subtopic, SUMMARY, Sydney, Teledoc, telemedicine, threshold, tolerance, tongue, Topic, tray, Treasury, treat, treating, twelve, uncollectible, unvested, upgrading, vest, vesting, volume, Warrant, workplace, world, yield
Removed:
American, arrangement, Biogenetic, borrow, borrowing, broader, capacity, certainty, directed, document, entrepreneur, exhaustive, Greatest, insufficiency, learning, manager, manual, multiple, newly, North, organized, preclude, presenting, president, preventative, Pty, real, restricted, select, standard, traditional, utilize
Financial reports
10-K
2020 FY
Annual report
11 Mar 21
10-Q
2020 Q3
Quarterly report
12 Nov 20
10-Q
2020 Q2
Quarterly report
13 Aug 20
10-Q
2020 Q1
Quarterly report
14 May 20
10-K
2019 FY
Annual report
21 Feb 20
10-Q
2019 Q3
Quarterly report
12 Nov 19
10-Q
2019 Q2
Quarterly report
5 Aug 19
10-Q
2019 Q1
Quarterly report
14 May 19
10-K
2018 FY
Annual report
28 Mar 19
10-Q
2018 Q3
Quarterly report
29 Oct 18
Current reports
8-K
Entry into a Material Definitive Agreement
26 Mar 21
8-K
USA Equities Corp (USAQ) Announces Physician Network Expansion Plans
23 Feb 21
8-K
USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami’s Allergy Diagnostics & Allergen Immunotherapy CME Conference
19 Feb 21
8-K
USA Equities Corp (USAQ) Announces Newest Advisory Board Members in First Quarter 2021
17 Feb 21
8-K
Regulation FD Disclosure
30 Dec 20
8-K
USA Equities Corp. (USAQ) and AllergiEnd Announces Allergy Testing Kit Distribution ahead of COVID-19 Vaccine
10 Dec 20
8-K
Regulation FD Disclosure
23 Nov 20
8-K
Regulation FD Disclosure
13 Nov 20
8-K
Entry into a Material Definitive Agreement
26 Oct 20
8-K
USA Equities Corp. (USAQ), Announces its Approval to Up-list to the OTCQB Venture Market
9 Oct 20
Registration and prospectus
D
$500K in debt / options, sold $55K, 2 investors
25 Sep 20
S-8
Registration of securities for employees
11 Mar 20
S-8
Registration of securities for employees
11 Sep 00
S-3
Shelf registration
1 May 00
S-3
Shelf registration
1 May 00
S-3
Shelf registration
1 May 00
S-8
Registration of securities for employees
19 Dec 99
424B3
Prospectus supplement
5 Jul 99
S-3/A
Shelf registration (amended)
21 Jun 99
S-3/A
Shelf registration (amended)
14 Apr 99
Proxies
DEF 14C
Information statement
11 Jun 15
PRE 14C
Preliminary information
31 May 15
DEF 14C
Information statement
3 Sep 08
PRE 14C
Preliminary information
9 Jul 08
DEF 14A
Definitive proxy
14 May 01
PRE 14A
Preliminary proxy
19 Apr 01
DEF 14A
Definitive proxy
30 Apr 00
PRE 14A
Preliminary proxy
12 Apr 00
DEF 14A
Definitive proxy
10 Feb 00
PRER14A
Preliminary revised proxy
6 Feb 00